$17.87
0.34% today
Nasdaq, Feb 28, 05:20 pm CET
ISIN
US8257041090
Symbol
SIBN

SI-BONE, Inc. Stock price

$17.81
+1.83 11.45% 1M
+1.33 8.07% 6M
+3.79 27.03% YTD
+0.05 0.28% 1Y
-4.25 19.27% 3Y
-1.51 7.82% 5Y
-2.25 11.22% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-0.34 1.87%
ISIN
US8257041090
Symbol
SIBN
Sector

Key metrics

Market capitalization $756.09m
Enterprise Value $643.53m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 3.85
P/S ratio (TTM) P/S ratio 4.52
P/B ratio (TTM) P/B ratio 4.49
Revenue growth (TTM) Revenue growth 20.37%
Revenue (TTM) Revenue $167.18m
EBIT (operating result TTM) EBIT $-35.25m
Free Cash Flow (TTM) Free Cash Flow $-22.92m
Cash position $150.04m
EPS (TTM) EPS $-0.75
P/E forward negative
P/S forward 3.90
EV/Sales forward 3.32
Short interest 2.76%
Show more

Is SI-BONE, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

SI-BONE, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a SI-BONE, Inc. forecast:

9x Buy
100%

Analyst Opinions

9 Analysts have issued a SI-BONE, Inc. forecast:

Buy
100%

Financial data from SI-BONE, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
167 167
20% 20%
100%
- Direct Costs 35 35
19% 19%
21%
132 132
21% 21%
79%
- Selling and Administrative Expenses 146 146
8% 8%
88%
- Research and Development Expense 17 17
10% 10%
10%
-31 -31
26% 26%
-18%
- Depreciation and Amortization 4.38 4.38
18% 18%
3%
EBIT (Operating Income) EBIT -35 -35
25% 25%
-21%
Net Profit -31 -31
29% 29%
-18%

In millions USD.

Don't miss a Thing! We will send you all news about SI-BONE, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

SI-BONE, Inc. Stock News

Neutral
Seeking Alpha
4 days ago
SI-BONE, Inc. (SIBN) Q4 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
4 days ago
Achieves 26% worldwide revenue growth and positive adjusted EBITDA in Fourth Quarter 2024 Achieves 26% worldwide revenue growth and positive adjusted EBITDA in Fourth Quarter 2024
Neutral
Business Wire
7 days ago
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Laura Francis to serve on its board as an independent director, effective as of February 18, 2025. Ms. Francis is also expected to join Bruker's Audit Committee as a financial expert after Bruker's annual shareholder meeting at the end of May 2025. Laura...
More SI-BONE, Inc. News

Company Profile

SI-BONE, Inc. is a medical device company. It focuses on the development of implantable devices used in the surgical treatment of the sacropelvic anatomy. The firm's product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in San Jose, CA.

Head office United States
CEO Laura Francis
Employees 349
Founded 2008
Website www.si-bone.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today